Precision Eyecare & Optical Optometrist Medicare: Medicare Enrolled Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 |
Bradley P Kepp Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 |
Dr. Zachary Mclean Oswald, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 |
Thomas S Kollodge Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 |
Dr. John Everett Creger, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 233 E Glendale St, Dillon, MT 59725 Phone: 406-683-2611 |
Dr. Douglas D Creger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 233 E Glendale St, Dillon, MT 59725 Phone: 406-683-2611 Fax: 406-683-2676 |
Douglas D Creger Od Optometrist Medicare: Medicare Enrolled Practice Location: 233 E Glendale St, Dillon, MT 59725 Phone: 406-683-2611 Fax: 406-683-2676 |
Dr. Bradley P Kepp, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 |
News Archive
Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.
The angiotensin-converting enzyme 2 (ACE2) enzyme attached to the membranes of cells is the entry point for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They are abundantly found all over the body and most prominently in the lungs and nose.
Use of one class of antidepressant drugs, the SSRIs (selective serotonin reuptake inhibitors), may be associated with severe violence in a small number of individuals say the authors of paper published in PLoS Medicine.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that an independent study conducted by the University of Edinburgh has successfully demonstrated the effectiveness of Covidien's Kendall SCD™ system with Vascular Refill Detection Technology on immobile stroke patients.
A new study led by researchers at Boston Medical Center indicates that variations in opioid receptor genes are associated with more severe neonatal abstinence syndrome (NAS) in newborn babies. The findings, published online in Drug & Alcohol Dependence, could help lead to the development of individualized treatment plans tailored to each infants' risk of requiring medication to curb their NAS symptoms, which could help improve these patients' outcomes and reduce how long some stay in the hospital.
› Verified 7 days ago